Which Emerging Trends Are Driving The Research Antibodies and Reagents Market Toward $26.25 Billion By 2029?
Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
What Are The Future Growth Projections For The Research Antibodies and Reagents Market Size?
In the past few years, the market size for research antibodies and reagents has robustly expanded. It is projected to escalate from $16.25 billion in 2024 to $17.4 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. The growth during the historical period is linked to factors such as the rise in pharmaceutical R&D spending, an aging population, increased healthcare spending, larger government funding for research, and an expansion in the number of healthcare facilities.
In the coming years, the market size for research antibodies and reagents is forecasted to experience substantial growth, reaching a valuation of $26.25 billion in 2029 with a compound annual growth rate (CAGR) of 10.8%. This anticipated growth throughout the projection period is due to factors such as a rising geriatric populace, amplified instances of cancer and chronic ailments, an upswing in research and development expenditures, an increase in health care spending, growing funding directed towards proteomics projects, proliferating demand for personalized medicine, and the emergence of infectious diseases. Key trends predicted for this span include a focus on utilizing nanotechnology to identify low-abundant molecules, introducing technologically advanced products to boost sales and profitability, emphasis on employing avant-garde antibody purification methodologies, consideration towards mergers and acquisitions with other research establishments and centers, and investments in research and development labs and initiatives.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3418&type=smp
Which Factors Are Steering Growth In The Research Antibodies and Reagents Market?
The rise in investment in healthcare and medical research and development (R&D) is projected to enhance the growth of the research antibodies and reagents market. Antibodies and reagents, which are indispensable in the domain of life science research, aid in the exploration of biological activities or origins of ailments through meticulous experimentation, surveillance, lab work, scrutiny, and verification. For example, as per the National Center for Science and Engineering Statistics (NCSES), a U.S.-based statistical organization, the research and experimental development (R&D) in the U.S. amounted to $789.1 billion in 2021 and is anticipated to escalate to $885.6 billion in 2022, signifying a growth of $84.1 billion. Consequently, the upsurge in investment in medical R&D will expedite the market penetration of research antibodies and reagents.
What Are The Main Segment Classifications In The Research Antibodies and Reagents Market?
The research antibodies and reagents market covered in this report is segmented –
1) By Technology: Western Blot, Immunofluorescence, Immunohistochemistry, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (Elisa), Others
2) By Application: Proteomics, Genomics, Other Applications
3) By End User: Pharmaceutical & Biotechnology Industry, Academic & Research Institutes, Contract Research Organizations (CROs)
Subsegments:
1) By Western Blot: Primary Antibodies For Western Blot, Secondary Antibodies For Western Blot, Detection Kits
2) By Immunofluorescence: Primary Antibodies For Immunofluorescence, Secondary Antibodies For Immunofluorescence, Fluorescent Dyes And Probes
3) By Immunohistochemistry: Primary Antibodies For Immunohistochemistry, Secondary Antibodies For Immunohistochemistry, Detection Kits
4) By Flow Cytometry: Fluorochrome-Conjugated Antibodies, Isotype Controls, Flow Cytometry Kits
5) By Enzyme-Linked Immunosorbent Assay (ELISA): Capture Antibodies, Detection Antibodies, ELISA Kits
6) By Others: Proteomics Reagents, Cell Culture Reagents, Antibody Conjugation Kits
How Are Industry Trends Steering The Expansion Of The Research Antibodies and Reagents Market?
Key players in the research antibodies and reagents market are concentrating their efforts on the creation of novel products like bispecific antibodies for antibody therapeutics. Bispecific antibodies (bsAbs) carry two antigen-binding sites and can hence target two dissimilar epitopes at once. For example, F. Hoffmann-La Roche AG, a pharmaceutical firm based in Switzerland, disclosed in January 2022 that the FDA gave approval to Vabysmo (Faricimab) for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME). Vabysmo (faricimab) holds the distinction of being the inaugural bispecific antibody developed specifically for the eye.
Which Companies Are Contributing Significantly To The Research Antibodies and Reagents Market Growth?
Major companies operating in the research antibodies and reagents market include Thermo Fisher Scientific Inc., Abcam plc, Cell Signaling Technology, Inc., Merck KGaA, Santa Cruz Biotechnology, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Johnson & Johnson, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Immunochina, Takara Bio, GE Healthcare, Zhejiang Kangte Biotechnology Co., Ltd., Wuxi Tech-star Technology Co., Ltd., Shaanxi Bloom Tech Co., Ltd., PerkinElmer Inc., Lonza Group AG, GenScript Biotech Corporation, Bio-Techne Corporation
Access The Complete Report Here:
Which Region Holds The Greatest Opportunity For Research Antibodies and Reagents Market Expansion?
North America was the largest region in the research antibodies and reagents market in 2024. The regions covered in the research antibodies and reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=3418&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
